Abstract
Objectives
This study investigated a large cohort of patients to construct a predictive nomogram and a web-based survival rate calculator for dynamically predicting the cancer-specific survival of patients with primary hypopharyngeal squamous cell carcinoma (HSCC).
Methods
Patients (n = 2007) initially diagnosed with primary HSCC from 2004 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. All patients were randomly divided into the training and validation cohorts (1:1). The Lasso Cox regression model was applied to identify independent risk factors of cancer-specific survival for a predictive nomogram and a web-based calculator. The model was evaluated by concordance index, calibration, and decision curve analysis.
Results
Cancer-specific survival rates decreased with time, while 3-year conditional survival increased. Cancer-specific deaths evolved from relatively high within the first 3 years to low thereafter. Age, race, T stage, N stage, M stage, surgery, radiotherapy, chemotherapy, and marital status were identified as independent risk factors. We constructed a predictive nomogram for survival and a web-based calculator (https://linzhongyang.shinyapps.io/Hypopharyngeal/). Additionally, a prognostic risk stratification was developed according to nomogram total points.
Conclusions
Patients with primary HSCC were found at a high risk of cancer-specific death during the first 3 years, indicating that additional effective follow-up strategies should be implemented over the period. This is the first study to construct a predictive nomogram and a web-based calculator for all patients with HSCC.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Hall SF, Groome PA, Irish J et al (2008) The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 118(8):1362–1371
Hoffman HT, Karnell LH, Shah JP et al (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107(8):1005–1017
Colevas AD, Yom SS, Pfister DG et al (2018) NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Cancer Netw 16(5):479–490
Henson DE, Schwartz AM, Chen D et al (2014) The clinical implications of integrating additional prognostic factors into the TNM. J Surg Oncol 109(5):391–394
Heng Y, Zhu X, Zhou L et al (2020) A prognostic nomogram for predicting the long-term survival outcome of hypopharyngeal squamous cell carcinoma patients after tumour resection to assist the decision-making of postoperative adjuvant treatment. Eur J Surg Oncol 46(2):245–251
Arends CR, Petersen JF, van der Noort V et al (2019) Optimizing survival predictions of hypopharynx cancer: development of a clinical prediction model. The Laryngoscope. https://doi.org/10.1002/lary.28345[published online ahead of print November 6 2019]
Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385–395
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-Tile. A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259
Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594
Kent DM, Steyerberg E, van Klaveren D (2018) Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ (Clin Res ed) 363:k4245
Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364–1370
Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173–e180
Necchi A, Sonpavde G, Vullo SL et al (2017) Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC). Eur Urol 71(2):281–289
Kim JH, Kim HS, Seo W et al (2011) External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer. Ann Oncol 23(2):361–367
Pan JJ, Ng WT, Zong JF et al (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(21):3307–3315
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17(6):1471–1474
Sharp L, McDevitt J, Carsin AE et al (2014) Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study. Cancer Epidemiol Biomarkers Prev 23(11):2579–2590
Ness-Jensen E, Gottlieb-Vedi E, Wahlin K et al (2018) All-cause and cancer-specific mortality in GORD in a population-based cohort study (the HUNT study). Gut 67(2):209–215
Swords DS, Mulvihill SJ, Firpo MA et al (2018) Causes of death and conditional survival estimates of medium- and long-term survivors of pancreatic adenocarcinoma. JAMA Oncol 4(8):1129–1130
Margonis GA, Buettner S, Andreatos N et al (2019) Prognostic factors change over time after hepatectomy for colorectal liver metastases: a multi-institutional, international analysis of 1099 patients. Ann Surg 269(6):1129–1137
Newman JR, Connolly TM, Illing EA et al (2015) Survival trends in Hypopharyngeal cancer: a population-based review. The Laryngoscope 125(3):624–629
Tulunay-Ugur OE, McClinton C, Young Z et al (2013) Functional outcomes of chemoradiation in patients with head and neck cancer. Otolaryngol Head Neck Surg 148(1):64–68
Lefebvre JL, Pointreau Y, Rolland F et al (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31(7):853–859
Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88(13):890–899
Machtay M, Moughan J, Farach A et al (2012) Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 84(4):983–989
Tassler AB, Gooding WE, Ferris RL (2019) Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit? Head Neck 41(7):2167–2173
Hochfelder CG, McGinn AP, Mehta V et al (2019) Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: a surveillance, epidemiology, and end results-based study. The Laryngoscope. https://doi.org/10.1002/lary.28452[published online ahead of print December 10 2019]
Harris BN, Biron VL, Donald P et al (2015) Primary surgery vs chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 141(7):636–640
Acknowledgements
The authors thank all the medical staff who contributed to the maintenance of the medical record database.
Funding
Not applicable.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Lin, Z., Lin, H. & Lin, C. Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma. Int J Clin Oncol 25, 1260–1269 (2020). https://doi.org/10.1007/s10147-020-01671-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-020-01671-4